Interstitial lung disease associated with adjuvant and neoadjuvant chemotherapy in early breast cancer

BACKGROUND: Interstitial lung disease (ILD) is a rare adverse event in patients receiving adjuvant or neoadjuvant chemotherapy (NAC) for breast cancer. Few studies have reported the frequency of ILD in detail, and only small numbers of cases have been described in the literature. Given these previou...

Descripción completa

Detalles Bibliográficos
Autores principales: Tezuka, Kenji, Miura, Kotaro, Nakano, Yusuke, Ueda, Takahiro, Yagyu, Kyoko, Matsuyama, Shimako, Shirai, Masami, Okuda, Hiroshi, Ujikawa, Miho, Ota, Takayo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196499/
https://www.ncbi.nlm.nih.gov/pubmed/34116698
http://dx.doi.org/10.1186/s12957-021-02289-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196499/
https://www.ncbi.nlm.nih.gov/pubmed/34116698
http://dx.doi.org/10.1186/s12957-021-02289-0

Ejemplares similares